Management of pediatric cardiac transplantation candidates with pulmonary hypertension and high pulmonary vascular resistance

On the con- trary, a pilot study to evaluate the effects of losartan on PAP, exercise capacity, quality of life, arterial blood gases and safety did not demonstrate any benefit

Methods: Between 2008 and 2011, 16 children (10 boys, 6 girls; mean age 4.97 years; range 8 months to 17 years) with a ventricular septal defect and associated severe pulmonary

Surgical or transcatheter intervention should be performed during the neonatal period to ensure the pulmonary blood flow in patients with pulmonary atresia.. A

[7] found that 13 out of 22 pediactric patients with congenital heart disease in conjunction with severe pulmonary hypertension and left-right shunt had a

The aim of this study was to define the hemodynamic parameters of patients undergoing cardiac catheterization in our center for congenital heart disease and pulmonary

Objective: To investigate preoperative and postoperative blood levels of soluble intercellular and vascular cell adhesion molecules (sICAM-1, sVCAM-1) in patients with and

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Figure 1 Transthoracic echocardiography view of an aneursym of pulmo- nary artery together with aneurysm of ascending aorta, pericardial effu- sion and right ventricular